AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/214
FAS APO-1 (CD95) EXPRESSION IN MYELODYSPLASTIC SYNDROMES/
Authors: LEPELLEY P GRARDEL N ERNY O IARU T OBEIN V COSSON A FENAUX P
Citation: P. Lepelley et al., FAS APO-1 (CD95) EXPRESSION IN MYELODYSPLASTIC SYNDROMES/, Leukemia & lymphoma, 30(3-4), 1998, pp. 307-312
EXPRESSION OF LUNG RESISTANCE PROTEIN AND CORRELATION WITH OTHER DRUG-RESISTANCE PROTEINS AND OUTCOME IN MYELODYSPLASTIC SYNDROMES
Authors: LEPELLEY P POULAIN S GRARDEL N PREUDHOMME C COSSON A FENAUX P
Citation: P. Lepelley et al., EXPRESSION OF LUNG RESISTANCE PROTEIN AND CORRELATION WITH OTHER DRUG-RESISTANCE PROTEINS AND OUTCOME IN MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 29(5-6), 1998, pp. 547-551
MYELODYSPLASIA DURING THE COURSE OF MYELOMA - RESTRICTION OF 17P DELETION AND P53 OVEREXPRESSION TO MYELOID CELLS
Authors: SOENEN V PREUDHOMME C ROUMIER C LAI JL LEPELLEY P FACON T PAGNIEZ D FENAUX P
Citation: V. Soenen et al., MYELODYSPLASIA DURING THE COURSE OF MYELOMA - RESTRICTION OF 17P DELETION AND P53 OVEREXPRESSION TO MYELOID CELLS, Leukemia, 12(2), 1998, pp. 238-241
AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMAS - THEROLE OF GRAFT PURGING AND RADIOTHERAPY POSTTRANSPLANTATION - RESULTS OF A RETROSPECTIVE ANALYSIS ON 120 PATIENTS AUTOGRAFTED IN A SINGLE INSTITUTION
Authors: FOUILLARD L LAPORTE JP LABOPIN M LESAGE S ISNARD F DOUAY L LOPEZ M AOUDJHANE M ZUNIC P CHERON N STACHOWIAK J LEMONNIER MP ANDREU G BELKACEMI Y NOELWALTER MP MOREL P FENAUX P JOUET JP BAUTERS F NAJMAN A GORIN NC
Citation: L. Fouillard et al., AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMAS - THEROLE OF GRAFT PURGING AND RADIOTHERAPY POSTTRANSPLANTATION - RESULTS OF A RETROSPECTIVE ANALYSIS ON 120 PATIENTS AUTOGRAFTED IN A SINGLE INSTITUTION, Journal of clinical oncology, 16(8), 1998, pp. 2803-2816
DIAGNOSIS, CLASSIFICATION, AND CYTOGENETICS OF MYELODYSPLASTIC SYNDROMES
Authors: VALLESPI T IMBERT M MECUCCI C PREUDHOMME C FENAUX P
Citation: T. Vallespi et al., DIAGNOSIS, CLASSIFICATION, AND CYTOGENETICS OF MYELODYSPLASTIC SYNDROMES, Haematologica, 83(3), 1998, pp. 258-275
TRANSLOCATION (3-13)(Q27-Q14) - A NONRANDOM AND PROBABLY SECONDARY STRUCTURAL-CHANGE IN NON-HODGKIN LYMPHOMAS
Authors: LAI JL DAUDIGNON A KERCKAERT JP GALIEGUEZOUITINA S DETOURMIGNIES L MOREL P BAUTERS F FENAUX P
Citation: Jl. Lai et al., TRANSLOCATION (3-13)(Q27-Q14) - A NONRANDOM AND PROBABLY SECONDARY STRUCTURAL-CHANGE IN NON-HODGKIN LYMPHOMAS, Cancer genetics and cytogenetics, 103(2), 1998, pp. 140-143
RETINOIC ACID SYNDROME - RECOGNITION, PREVENTION AND MANAGEMENT
Authors: FENAUX P DEBOTTON S
Citation: P. Fenaux et S. Debotton, RETINOIC ACID SYNDROME - RECOGNITION, PREVENTION AND MANAGEMENT, Drug safety, 18(4), 1998, pp. 273-279
RADIATION-RESISTANCE OF FIBEROPTIC COMPONENTS AND PREDICTIVE MODELS FOR OPTICAL-FIBER SYSTEMS IN NUCLEAR ENVIRONMENTS
Authors: VANUFFELEN M JUCKER P FENAUX P
Citation: M. Vanuffelen et al., RADIATION-RESISTANCE OF FIBEROPTIC COMPONENTS AND PREDICTIVE MODELS FOR OPTICAL-FIBER SYSTEMS IN NUCLEAR ENVIRONMENTS, IEEE transactions on nuclear science, 45(3), 1998, pp. 1558-1565
QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MAHE B MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F BUZYN A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A STAMATOULAS A TILLY H BRICE P MALOISEL F LIOURE B DESABLENS B PIGNON B ABGRALL JP LEPORRIER M DUPRIEZ B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(4), 1998, pp. 1015-1024
ACUTE PROMYELOCYTIC LEUKEMIA - PROGNOSTIC-SIGNIFICANCE OF PML-RAR-ALPHA TYPING AND IN-VITRO ATRA DIFFERENTIATING EFFICIENCY ON LEUKEMIC BLASTS
Authors: CASSINAT B CHEVRET S BALITRAND N ZASSADOWSKI F BARBEY C RAIN JD DEGOS L FENAUX P CHOMIENNE C
Citation: B. Cassinat et al., ACUTE PROMYELOCYTIC LEUKEMIA - PROGNOSTIC-SIGNIFICANCE OF PML-RAR-ALPHA TYPING AND IN-VITRO ATRA DIFFERENTIATING EFFICIENCY ON LEUKEMIC BLASTS, British Journal of Haematology, 102(1), 1998, pp. 14-14
EVALUATION OF MINIMAL RESIDUAL DISEASE USING RT-PCR IN 37 T(8,21) AMLPATIENTS
Authors: MORSCHHAUSER F CAYUELA JM MARTINI S BARUCHEL A ROUSSELOT P SOCIE G JOUET JP STRAETMANS N MARTIAT P FENAUX P PREUDHOMME C
Citation: F. Morschhauser et al., EVALUATION OF MINIMAL RESIDUAL DISEASE USING RT-PCR IN 37 T(8,21) AMLPATIENTS, British Journal of Haematology, 102(1), 1998, pp. 99-99
DIAGNOSIS AND FOLLOW-UP OF MINIMAL RESIDUAL DISEASE (MRD) IN APL USING FISH ANALYSIS
Authors: MORSCHHAUSER F FOURNIER M FENAUX P CHOMIENNE C PREUDHOMME C
Citation: F. Morschhauser et al., DIAGNOSIS AND FOLLOW-UP OF MINIMAL RESIDUAL DISEASE (MRD) IN APL USING FISH ANALYSIS, British Journal of Haematology, 102(1), 1998, pp. 100-100
IMMUNOCYTOCHEMISTRY - A SUITABLE METHOD FOR DETECTION OF P16 HOMOZYGOUS DELETION IN ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: SOENEN V LEPELLEY P LAI JL VANRUMBEKE M PREUDHOMME C BAUTERS F FENAUX P QUESNEL B
Citation: V. Soenen et al., IMMUNOCYTOCHEMISTRY - A SUITABLE METHOD FOR DETECTION OF P16 HOMOZYGOUS DELETION IN ACUTE LYMPHOBLASTIC-LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 103-103
ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY TIMED SEQUENTIAL CHEMOTHERAPY (EMA) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Authors: THOMAS X CORDONNIER C DOMBRET H FEGUEUX N MALOISEL F VEKHOFF A REMAN O VILQUE JP GRATECOS N DEREVEL T COASIN T BUZYN A CAHN JY GUERCI A CHOMIENNE C ARCHIMBAUD E DEGOS L FENAUX P
Citation: X. Thomas et al., ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY TIMED SEQUENTIAL CHEMOTHERAPY (EMA) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA (APL), British Journal of Haematology, 102(1), 1998, pp. 150-150
GM-CSF TO INCREASE EFFICACY OF SEQUENTIAL CHEMOTHERAPY IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL (EMA91)
Authors: ARCHIMBAUD E FENAUX P DOMBRET H DREYFUS F TILLY H CONYMAKHOUL P LEBLOND V TROUSSARD X DELAIR S FFRENCH M MARIE JP
Citation: E. Archimbaud et al., GM-CSF TO INCREASE EFFICACY OF SEQUENTIAL CHEMOTHERAPY IN PREVIOUSLY TREATED ACUTE MYELOID-LEUKEMIA (AML) - FINAL RESULTS OF A MULTICENTER RANDOMIZED TRIAL (EMA91), British Journal of Haematology, 102(1), 1998, pp. 151-151
INTENSIFIED INDUCTION CHEMOTHERAPY INCREASE REMISSION DURATION IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) PATIENTS AGED LESS-THAN 50 YEARS - LONG-TERM RESULTS OF LAM-90 TRIAL
Authors: CASTAIGNE S ARCHIMBAUD A BORDESSOULE D TILLY H DOMBRET H DEREVEL T SIMON M RENOUX M JANVIER M GROSBOIS M DUPRIEZ B ZINI JM TERTIAN G BAY O FENAUX P DEGOS L CHASTANG C
Citation: S. Castaigne et al., INTENSIFIED INDUCTION CHEMOTHERAPY INCREASE REMISSION DURATION IN DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) PATIENTS AGED LESS-THAN 50 YEARS - LONG-TERM RESULTS OF LAM-90 TRIAL, British Journal of Haematology, 102(1), 1998, pp. 220-220
INVESTIGATION OF MINIMAL RESIDUAL DISEASE (MRD) IN PH-1 POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) BY A COMBINATION OF CELL SORTING (CD34-SITU HYBRIDIZATION (FISH)( CELLS) AND FLUORESCENCE IN)
Authors: CAMBIER N COSSEMENT C COSSON A LAI JL FENAUX P PREUDHOMME C
Citation: N. Cambier et al., INVESTIGATION OF MINIMAL RESIDUAL DISEASE (MRD) IN PH-1 POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) BY A COMBINATION OF CELL SORTING (CD34-SITU HYBRIDIZATION (FISH)( CELLS) AND FLUORESCENCE IN), British Journal of Haematology, 102(1), 1998, pp. 275-275
QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F VEIL A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A TILLY H BRICE B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTICSYNDROMES (MDS) EXPRESSING P-GLYCOPROTEIN (PGP) - UPDATED RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(1), 1998, pp. 282-282
DETECTION OF BCR-ABL TRANSCRIPTS IN CHRONIC MYELOID-LEUKEMIA (CML) USING A NOVEL REAL-TIME QUANTITATIVE RT-PCR ASSAY (TAQ MAN CHEMISTRY)
Authors: PREUDHOMME C HORNEZ L MERLAT A PRUVOT D LAINE AL COSSON A PEYRAT JP FENAUX P
Citation: C. Preudhomme et al., DETECTION OF BCR-ABL TRANSCRIPTS IN CHRONIC MYELOID-LEUKEMIA (CML) USING A NOVEL REAL-TIME QUANTITATIVE RT-PCR ASSAY (TAQ MAN CHEMISTRY), British Journal of Haematology, 102(1), 1998, pp. 291-291
EVALUATION OF MINIMAL RESIDUAL DISEASE USING REAL-TIME QUANTITATIVE RT-PCR (TAQ MAN CHEMISTRY) IN T(8,21) AML PATIENTS
Authors: SMETSERS T CAYUELA JM MORSCHHAUSER F MARTINI S MENSINK EJBM FENAUX P PREUDHOMME C
Citation: T. Smetsers et al., EVALUATION OF MINIMAL RESIDUAL DISEASE USING REAL-TIME QUANTITATIVE RT-PCR (TAQ MAN CHEMISTRY) IN T(8,21) AML PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 291-291
AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS)
Authors: WATTEL E LELEU X SOLARY E CAILLOT D DREYFUS F BRION A MAHE B JOUET JP HOANGNGOC L MALOISEL F GUERCI A ROCHANT H GRATECOS N SADOUN A STAMATOULLAS A CASASSUS P JANVIER M STOPPA AM DESABLENS B FEGUEUX N GUYOTAT D BRICE P LEPELLEY P FENAUX P
Citation: E. Wattel et al., AUTOLOGOUS BONE-MARROW (ABMT) OR PERIPHERAL-BLOOD STEM-CELL (ABSCT) TRANSPLANTATION AFTER INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES (MDS), British Journal of Haematology, 102(1), 1998, pp. 320-321
9-CIS-RETINOIC ACID TREATMENT FOR MYELODYSPLASIA
Authors: KELL WJ HOFMANN WK HOELZER D CHOMIENNE C GANSER A FENAUX P CASTAIGNE S BURNETT R BURNETT AK
Citation: Wj. Kell et al., 9-CIS-RETINOIC ACID TREATMENT FOR MYELODYSPLASIA, British Journal of Haematology, 101, 1998, pp. 167-167
A NEW CASE OF THERAPY-RELATED ACUTE MYELOID-LEUKEMIA WITH T(8-16)(P11-P13)
Authors: MICHALLET AS LAI JL BAUTERS F FENAUX P QUESNEL B
Citation: As. Michallet et al., A NEW CASE OF THERAPY-RELATED ACUTE MYELOID-LEUKEMIA WITH T(8-16)(P11-P13), British Journal of Haematology, 100(4), 1998, pp. 801-802
VERY-LOW INCIDENCE OF P53 ANTIBODIES IN ADULT NON-HODGKINS-LYMPHOMA AND MULTIPLE-MYELOMA
Authors: PREUDHOMME C VANRUMBEKE M DETOURMIGNIES L FACON T LEPELLEY P SOUSSI T FENAUX P
Citation: C. Preudhomme et al., VERY-LOW INCIDENCE OF P53 ANTIBODIES IN ADULT NON-HODGKINS-LYMPHOMA AND MULTIPLE-MYELOMA, British Journal of Haematology, 100(1), 1998, pp. 184-186
INCIDENCE, CLINICAL-FEATURES, AND OUTCOME OF ALL-TRANS-RETINOIC ACID SYNDROME IN 413 CASES OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
Authors: DEBOTTON S DOMBRET H SANZ M SANMIGUEL J CAILLOT D ZITTOUN R GARDEMBAS M STAMATOULAS A CONDE E GUERCI A GARDIN C GEISER K MAKHOUL DC REMAN O DELASERNA J LEFRERE F CHOMIENNE C CHASTANG C DEGOS L FENAUX P
Citation: S. Debotton et al., INCIDENCE, CLINICAL-FEATURES, AND OUTCOME OF ALL-TRANS-RETINOIC ACID SYNDROME IN 413 CASES OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA, Blood, 92(8), 1998, pp. 2712-2718
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>